Clinical Trials Directory

Trials / Completed

CompletedNCT00803803

Dose, Effects and Characteristics of Pilocarpine

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
37 (actual)
Sponsor
Wills Eye · Academic / Other
Sex
All
Age
18 Years – 90 Years
Healthy volunteers
Not accepted

Summary

The purpose of this investigation, in which pilocarpine was given in repeated doses, was to evaluate: Part I - the effects of different concentrations of pilocarpine hydrochloride on intraocular pressure. Part II -the effects on intraocular pressure of glaucomatous patients to pilocarpine 2% when given once, twice and four daily. In addition, we studied various attributes of the eye which may serve as indicators of responsiveness of individual patients to pilocarpine.

Detailed description

In addition, we studied various attributes of the eye which may serve as indicators of responsiveness of individual patients to pilocarpine.

Conditions

Interventions

TypeNameDescription
DRUGPilocarpine ConcentrationVarying concentration 0.5 to 8%
DRUGPilocarpine Frequency1 to 4 times daily

Timeline

Start date
1978-08-01
Primary completion
1979-08-01
Completion
1979-12-01
First posted
2008-12-08
Last updated
2016-11-22

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00803803. Inclusion in this directory is not an endorsement.

Dose, Effects and Characteristics of Pilocarpine (NCT00803803) · Clinical Trials Directory